The Elusive Horizon : Biomarkers in Urothelial Carcinoma
Copyright © 2024 European Association of Urology. Published by Elsevier B.V. All rights reserved..
Urinary tests for circulating tumor DNA have potential for accurate discrimination of bladder cancer from other common inflammatory processes. Efforts are still needed to determine whether these tests can differentiate between cancer and field cancerization and to demonstrate clinical benefit in prospective trials.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:85 |
|---|---|
| Enthalten in: |
European urology - 85(2024), 4 vom: 14. März, Seite 317-319 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Linscott, Joshua A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 18.03.2024 Date Revised 18.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.eururo.2024.01.004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36769073X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36769073X | ||
| 003 | DE-627 | ||
| 005 | 20240318234136.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240127s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.eururo.2024.01.004 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1334.xml |
| 035 | |a (DE-627)NLM36769073X | ||
| 035 | |a (NLM)38278663 | ||
| 035 | |a (PII)S0302-2838(24)00006-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Linscott, Joshua A |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Elusive Horizon |b Biomarkers in Urothelial Carcinoma |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.03.2024 | ||
| 500 | |a Date Revised 18.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 European Association of Urology. Published by Elsevier B.V. All rights reserved. | ||
| 520 | |a Urinary tests for circulating tumor DNA have potential for accurate discrimination of bladder cancer from other common inflammatory processes. Efforts are still needed to determine whether these tests can differentiate between cancer and field cancerization and to demonstrate clinical benefit in prospective trials | ||
| 650 | 4 | |a Editorial | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 650 | 7 | |a Circulating Tumor DNA |2 NLM | |
| 650 | 7 | |a Biomarkers, Tumor |2 NLM | |
| 700 | 1 | |a Meeks, Joshua J |e verfasserin |4 aut | |
| 700 | 1 | |a Dyrskjøt, Lars |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Roger |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European urology |d 1977 |g 85(2024), 4 vom: 14. März, Seite 317-319 |w (DE-627)NLM000137588 |x 1873-7560 |7 nnns |
| 773 | 1 | 8 | |g volume:85 |g year:2024 |g number:4 |g day:14 |g month:03 |g pages:317-319 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.eururo.2024.01.004 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 85 |j 2024 |e 4 |b 14 |c 03 |h 317-319 | ||